MEEDER ASSET MANAGEMENT INC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$3,000
+50.0%
581
-68.0%
0.00%
Q4 2018$2,000
+100.0%
1,818
+369.8%
0.00%
Q1 2018$1,0000.0%387
+66.1%
0.00%
Q4 2017$1,000
-50.0%
233
+46.5%
0.00%
Q3 2017$2,000
-33.3%
159
-53.2%
0.00%
Q2 2017$3,000
+50.0%
3400.0%0.00%
Q1 2017$2,000
-77.8%
340
-80.0%
0.00%
-100.0%
Q4 2016$9,0001,6960.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2016
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders